Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.6545 -0.0056 (-0.85%)
Streaming Delayed Price Updated: 12:30 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 85,818
Open 0.6890
Bid (Size) 0.6500 (1,200)
Ask (Size) 0.6546 (200)
Prev. Close 0.6601
Today's Range 0.6310 - 0.6905
52wk Range 0.6510 - 1.600
Shares Outstanding 36,187,798
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Investor Summit | MicroCap Opportunities to Watch - August 26
From Investor Summit Group
Via ACCESS Newswire
News headline image
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript ↗
Company advances commercialization with initial product shipments and distribution deals. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-30.4%
-30.4%
1 Month
-42.1%
-42.1%
3 Month
-13.9%
-13.9%
6 Month
-22.0%
-22.0%
1 Year
-27.7%
-27.7%

More News

Read More
MissionIRNewsBreaks – Dyadic International, Inc. (NASDAQ: DYAI) Entered Agreements for $2.9 Million Registered Direct Offering and Private Placement
Via Investor Brand Network
News headline image
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
From Dyadic International, Inc.
Via GlobeNewswire
Dyadic International Inc (NASDAQ:DYAI) Q1 Report Beats Revenue Expectations but EPS Miss Triggers 28% After-Market Selloff ↗
Via Chartmill
Dyadic International Inc (NASDAQ:DYAI) Reports Q4 2025 Earnings Miss, Stock Dips ↗
Via Chartmill
Topics Earnings
News headline image
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Announces Continued Listing on the Nasdaq Capital Market
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
From Dyadic International, Inc.
Via GlobeNewswire
Which stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Expands IP Protection and Business Development Activities in Japan
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic (DYAI) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic (DYAI) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)
From Dyadic International, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Dyadic International, Inc. - Common Stock publicly traded?
Yes, Dyadic International, Inc. - Common Stock is publicly traded.
What exchange does Dyadic International, Inc. - Common Stock trade on?
Dyadic International, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dyadic International, Inc. - Common Stock?
The ticker symbol for Dyadic International, Inc. - Common Stock is DYAI on the Nasdaq Stock Market
What is the current price of Dyadic International, Inc. - Common Stock?
The current price of Dyadic International, Inc. - Common Stock is 0.6545
When was Dyadic International, Inc. - Common Stock last traded?
The last trade of Dyadic International, Inc. - Common Stock was at 08/27/26 12:30 PM ET
What is the market capitalization of Dyadic International, Inc. - Common Stock?
The market capitalization of Dyadic International, Inc. - Common Stock is 23.68M
How many shares of Dyadic International, Inc. - Common Stock are outstanding?
Dyadic International, Inc. - Common Stock has 24M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.